nodes	percent_of_prediction	percent_of_DWPC	metapath
Clomifene—ABCB1—Lisinopril—dilated cardiomyopathy	0.144	0.532	CbGbCtD
Clomifene—KCNH2—purkinje fiber—dilated cardiomyopathy	0.136	0.513	CbGeAlD
Clomifene—ABCB1—Spironolactone—dilated cardiomyopathy	0.127	0.468	CbGbCtD
Clomifene—KCNH2—endocardium—dilated cardiomyopathy	0.07	0.264	CbGeAlD
Clomifene—Carcinoma breast—Spironolactone—dilated cardiomyopathy	0.0661	0.152	CcSEcCtD
Clomifene—Patent ductus arteriosus—Furosemide—dilated cardiomyopathy	0.0584	0.135	CcSEcCtD
Clomifene—Breast cancer—Spironolactone—dilated cardiomyopathy	0.0245	0.0565	CcSEcCtD
Clomifene—Hypertrichosis—Spironolactone—dilated cardiomyopathy	0.0235	0.0542	CcSEcCtD
Clomifene—Unspecified visual loss—Lisinopril—dilated cardiomyopathy	0.0167	0.0385	CcSEcCtD
Clomifene—Hypovolaemia—Furosemide—dilated cardiomyopathy	0.0157	0.0362	CcSEcCtD
Clomifene—Aprindine—SCN5A—dilated cardiomyopathy	0.0123	0.718	CrCbGaD
Clomifene—Abdominal bloating—Furosemide—dilated cardiomyopathy	0.0102	0.0236	CcSEcCtD
Clomifene—Blood triglycerides increased—Furosemide—dilated cardiomyopathy	0.00743	0.0171	CcSEcCtD
Clomifene—SIGMAR1—cardiac ventricle—dilated cardiomyopathy	0.0074	0.0279	CbGeAlD
Clomifene—SIGMAR1—myocardium—dilated cardiomyopathy	0.00696	0.0263	CbGeAlD
Clomifene—Thrombosis—Furosemide—dilated cardiomyopathy	0.00688	0.0158	CcSEcCtD
Clomifene—Blindness—Lisinopril—dilated cardiomyopathy	0.0066	0.0152	CcSEcCtD
Clomifene—Cholestasis—Furosemide—dilated cardiomyopathy	0.00641	0.0148	CcSEcCtD
Clomifene—KCNH2—cardiac ventricle—dilated cardiomyopathy	0.00589	0.0222	CbGeAlD
Clomifene—KCNH2—myocardium—dilated cardiomyopathy	0.00554	0.0209	CbGeAlD
Clomifene—CYP1A1—cardiac ventricle—dilated cardiomyopathy	0.00497	0.0188	CbGeAlD
Clomifene—Renal failure—Spironolactone—dilated cardiomyopathy	0.00492	0.0113	CcSEcCtD
Clomifene—SIGMAR1—heart—dilated cardiomyopathy	0.00486	0.0183	CbGeAlD
Clomifene—Lightheadedness—Furosemide—dilated cardiomyopathy	0.00435	0.01	CcSEcCtD
Clomifene—ESR1—heart—dilated cardiomyopathy	0.00429	0.0162	CbGeAlD
Clomifene—Erythema multiforme—Spironolactone—dilated cardiomyopathy	0.00425	0.00979	CcSEcCtD
Clomifene—Mental disability—Furosemide—dilated cardiomyopathy	0.00422	0.00973	CcSEcCtD
Clomifene—SIGMAR1—cardiac atrium—dilated cardiomyopathy	0.00415	0.0157	CbGeAlD
Clomifene—Thrombophlebitis—Furosemide—dilated cardiomyopathy	0.00408	0.0094	CcSEcCtD
Clomifene—Alopecia—Spironolactone—dilated cardiomyopathy	0.00397	0.00915	CcSEcCtD
Clomifene—Deafness—Furosemide—dilated cardiomyopathy	0.00395	0.0091	CcSEcCtD
Clomifene—Leukocytosis—Lisinopril—dilated cardiomyopathy	0.00389	0.00895	CcSEcCtD
Clomifene—KCNH2—heart—dilated cardiomyopathy	0.00387	0.0146	CbGeAlD
Clomifene—Pulmonary embolism—Lisinopril—dilated cardiomyopathy	0.00365	0.00841	CcSEcCtD
Clomifene—Photophobia—Lisinopril—dilated cardiomyopathy	0.00343	0.0079	CcSEcCtD
Clomifene—Irritability—Furosemide—dilated cardiomyopathy	0.00337	0.00777	CcSEcCtD
Clomifene—KCNH2—cardiac atrium—dilated cardiomyopathy	0.00331	0.0125	CbGeAlD
Clomifene—Lightheadedness—Lisinopril—dilated cardiomyopathy	0.00327	0.00753	CcSEcCtD
Clomifene—CYP1A1—heart—dilated cardiomyopathy	0.00326	0.0123	CbGeAlD
Clomifene—Abdominal distension—Furosemide—dilated cardiomyopathy	0.00307	0.00708	CcSEcCtD
Clomifene—Pancreatitis—Furosemide—dilated cardiomyopathy	0.00299	0.0069	CcSEcCtD
Clomifene—Diphenhydramine—SLC22A5—dilated cardiomyopathy	0.00285	0.167	CrCbGaD
Clomifene—Pollakiuria—Furosemide—dilated cardiomyopathy	0.00282	0.0065	CcSEcCtD
Clomifene—CYP1A1—cardiac atrium—dilated cardiomyopathy	0.00279	0.0105	CbGeAlD
Clomifene—Cerebrovascular accident—Lisinopril—dilated cardiomyopathy	0.00271	0.00623	CcSEcCtD
Clomifene—Renal failure—Furosemide—dilated cardiomyopathy	0.00268	0.00617	CcSEcCtD
Clomifene—Diplopia—Lisinopril—dilated cardiomyopathy	0.00265	0.00611	CcSEcCtD
Clomifene—Urticaria—Spironolactone—dilated cardiomyopathy	0.00254	0.00584	CcSEcCtD
Clomifene—Irritability—Lisinopril—dilated cardiomyopathy	0.00253	0.00583	CcSEcCtD
Clomifene—Body temperature increased—Spironolactone—dilated cardiomyopathy	0.00252	0.00581	CcSEcCtD
Clomifene—Visual impairment—Furosemide—dilated cardiomyopathy	0.00236	0.00543	CcSEcCtD
Clomifene—Hypersensitivity—Spironolactone—dilated cardiomyopathy	0.00235	0.00542	CcSEcCtD
Clomifene—Erythema multiforme—Furosemide—dilated cardiomyopathy	0.00231	0.00532	CcSEcCtD
Clomifene—Tinnitus—Furosemide—dilated cardiomyopathy	0.00228	0.00525	CcSEcCtD
Clomifene—Pruritus—Spironolactone—dilated cardiomyopathy	0.00226	0.0052	CcSEcCtD
Clomifene—Pancreatitis—Lisinopril—dilated cardiomyopathy	0.00225	0.00518	CcSEcCtD
Clomifene—Diarrhoea—Spironolactone—dilated cardiomyopathy	0.00218	0.00503	CcSEcCtD
Clomifene—Arrhythmia—Furosemide—dilated cardiomyopathy	0.00218	0.00503	CcSEcCtD
Clomifene—Erythema—Furosemide—dilated cardiomyopathy	0.00213	0.0049	CcSEcCtD
Clomifene—Dizziness—Spironolactone—dilated cardiomyopathy	0.00211	0.00486	CcSEcCtD
Clomifene—Flatulence—Furosemide—dilated cardiomyopathy	0.0021	0.00483	CcSEcCtD
Clomifene—Weight increased—Lisinopril—dilated cardiomyopathy	0.00209	0.0048	CcSEcCtD
Clomifene—Vomiting—Spironolactone—dilated cardiomyopathy	0.00203	0.00468	CcSEcCtD
Clomifene—Rash—Spironolactone—dilated cardiomyopathy	0.00201	0.00464	CcSEcCtD
Clomifene—Dermatitis—Spironolactone—dilated cardiomyopathy	0.00201	0.00463	CcSEcCtD
Clomifene—Renal failure—Lisinopril—dilated cardiomyopathy	0.00201	0.00463	CcSEcCtD
Clomifene—Vision blurred—Furosemide—dilated cardiomyopathy	0.00201	0.00462	CcSEcCtD
Clomifene—Headache—Spironolactone—dilated cardiomyopathy	0.002	0.00461	CcSEcCtD
Clomifene—Jaundice—Lisinopril—dilated cardiomyopathy	0.00199	0.00459	CcSEcCtD
Clomifene—Phenoxybenzamine—ADRB2—dilated cardiomyopathy	0.00197	0.116	CrCbGaD
Clomifene—Vertigo—Furosemide—dilated cardiomyopathy	0.00191	0.0044	CcSEcCtD
Clomifene—Nausea—Spironolactone—dilated cardiomyopathy	0.0019	0.00437	CcSEcCtD
Clomifene—Hepatitis—Lisinopril—dilated cardiomyopathy	0.00183	0.00423	CcSEcCtD
Clomifene—Erythema multiforme—Lisinopril—dilated cardiomyopathy	0.00173	0.00399	CcSEcCtD
Clomifene—Tinnitus—Lisinopril—dilated cardiomyopathy	0.00171	0.00394	CcSEcCtD
Clomifene—Shock—Furosemide—dilated cardiomyopathy	0.00171	0.00394	CcSEcCtD
Clomifene—Flushing—Lisinopril—dilated cardiomyopathy	0.0017	0.00392	CcSEcCtD
Clomifene—ABCB1—heart—dilated cardiomyopathy	0.0017	0.00641	CbGeAlD
Clomifene—Arrhythmia—Lisinopril—dilated cardiomyopathy	0.00164	0.00377	CcSEcCtD
Clomifene—Alopecia—Lisinopril—dilated cardiomyopathy	0.00162	0.00373	CcSEcCtD
Clomifene—Erythema—Lisinopril—dilated cardiomyopathy	0.0016	0.00368	CcSEcCtD
Clomifene—Flatulence—Lisinopril—dilated cardiomyopathy	0.00157	0.00362	CcSEcCtD
Clomifene—Tension—Lisinopril—dilated cardiomyopathy	0.00157	0.00361	CcSEcCtD
Clomifene—Paraesthesia—Furosemide—dilated cardiomyopathy	0.00156	0.00359	CcSEcCtD
Clomifene—Nervousness—Lisinopril—dilated cardiomyopathy	0.00155	0.00357	CcSEcCtD
Clomifene—Back pain—Lisinopril—dilated cardiomyopathy	0.00154	0.00356	CcSEcCtD
Clomifene—Vision blurred—Lisinopril—dilated cardiomyopathy	0.0015	0.00347	CcSEcCtD
Clomifene—Fatigue—Furosemide—dilated cardiomyopathy	0.0015	0.00345	CcSEcCtD
Clomifene—Constipation—Furosemide—dilated cardiomyopathy	0.00148	0.00342	CcSEcCtD
Clomifene—Pain—Furosemide—dilated cardiomyopathy	0.00148	0.00342	CcSEcCtD
Clomifene—Vertigo—Lisinopril—dilated cardiomyopathy	0.00143	0.0033	CcSEcCtD
Clomifene—Syncope—Lisinopril—dilated cardiomyopathy	0.00143	0.0033	CcSEcCtD
Clomifene—Palpitations—Lisinopril—dilated cardiomyopathy	0.00141	0.00325	CcSEcCtD
Clomifene—Loss of consciousness—Lisinopril—dilated cardiomyopathy	0.0014	0.00323	CcSEcCtD
Clomifene—Urticaria—Furosemide—dilated cardiomyopathy	0.00138	0.00318	CcSEcCtD
Clomifene—Body temperature increased—Furosemide—dilated cardiomyopathy	0.00137	0.00316	CcSEcCtD
Clomifene—Arthralgia—Lisinopril—dilated cardiomyopathy	0.00136	0.00313	CcSEcCtD
Clomifene—Chest pain—Lisinopril—dilated cardiomyopathy	0.00136	0.00313	CcSEcCtD
Clomifene—Myalgia—Lisinopril—dilated cardiomyopathy	0.00136	0.00313	CcSEcCtD
Clomifene—Anxiety—Lisinopril—dilated cardiomyopathy	0.00135	0.00312	CcSEcCtD
Clomifene—Oedema—Lisinopril—dilated cardiomyopathy	0.0013	0.003	CcSEcCtD
Clomifene—Shock—Lisinopril—dilated cardiomyopathy	0.00128	0.00295	CcSEcCtD
Clomifene—Hypersensitivity—Furosemide—dilated cardiomyopathy	0.00128	0.00295	CcSEcCtD
Clomifene—Tachycardia—Lisinopril—dilated cardiomyopathy	0.00127	0.00293	CcSEcCtD
Clomifene—Asthenia—Furosemide—dilated cardiomyopathy	0.00125	0.00287	CcSEcCtD
Clomifene—Pruritus—Furosemide—dilated cardiomyopathy	0.00123	0.00283	CcSEcCtD
Clomifene—Diarrhoea—Furosemide—dilated cardiomyopathy	0.00119	0.00274	CcSEcCtD
Clomifene—Musculoskeletal discomfort—Lisinopril—dilated cardiomyopathy	0.00119	0.00273	CcSEcCtD
Clomifene—Insomnia—Lisinopril—dilated cardiomyopathy	0.00118	0.00272	CcSEcCtD
Clomifene—Paraesthesia—Lisinopril—dilated cardiomyopathy	0.00117	0.0027	CcSEcCtD
Clomifene—Dyspnoea—Lisinopril—dilated cardiomyopathy	0.00116	0.00268	CcSEcCtD
Clomifene—Dizziness—Furosemide—dilated cardiomyopathy	0.00115	0.00265	CcSEcCtD
Clomifene—Fatigue—Lisinopril—dilated cardiomyopathy	0.00112	0.00259	CcSEcCtD
Clomifene—Pain—Lisinopril—dilated cardiomyopathy	0.00111	0.00257	CcSEcCtD
Clomifene—Constipation—Lisinopril—dilated cardiomyopathy	0.00111	0.00257	CcSEcCtD
Clomifene—Vomiting—Furosemide—dilated cardiomyopathy	0.0011	0.00254	CcSEcCtD
Clomifene—Rash—Furosemide—dilated cardiomyopathy	0.00109	0.00252	CcSEcCtD
Clomifene—Dermatitis—Furosemide—dilated cardiomyopathy	0.00109	0.00252	CcSEcCtD
Clomifene—Headache—Furosemide—dilated cardiomyopathy	0.00109	0.00251	CcSEcCtD
Clomifene—Urticaria—Lisinopril—dilated cardiomyopathy	0.00104	0.00238	CcSEcCtD
Clomifene—Nausea—Furosemide—dilated cardiomyopathy	0.00103	0.00238	CcSEcCtD
Clomifene—Body temperature increased—Lisinopril—dilated cardiomyopathy	0.00103	0.00237	CcSEcCtD
Clomifene—Hypersensitivity—Lisinopril—dilated cardiomyopathy	0.00096	0.00221	CcSEcCtD
Clomifene—Asthenia—Lisinopril—dilated cardiomyopathy	0.000935	0.00215	CcSEcCtD
Clomifene—Pruritus—Lisinopril—dilated cardiomyopathy	0.000922	0.00212	CcSEcCtD
Clomifene—Diarrhoea—Lisinopril—dilated cardiomyopathy	0.000891	0.00205	CcSEcCtD
Clomifene—Dizziness—Lisinopril—dilated cardiomyopathy	0.000862	0.00199	CcSEcCtD
Clomifene—Vomiting—Lisinopril—dilated cardiomyopathy	0.000828	0.00191	CcSEcCtD
Clomifene—Rash—Lisinopril—dilated cardiomyopathy	0.000822	0.00189	CcSEcCtD
Clomifene—Dermatitis—Lisinopril—dilated cardiomyopathy	0.000821	0.00189	CcSEcCtD
Clomifene—Headache—Lisinopril—dilated cardiomyopathy	0.000816	0.00188	CcSEcCtD
Clomifene—ESR1—LKB1 signaling events—SIK1—dilated cardiomyopathy	0.000793	0.0633	CbGpPWpGaD
Clomifene—Nausea—Lisinopril—dilated cardiomyopathy	0.000774	0.00178	CcSEcCtD
Clomifene—KCNH2—Hematopoietic Stem Cell Differentiation—CSF3—dilated cardiomyopathy	0.000549	0.0439	CbGpPWpGaD
Clomifene—ESR1—FOXM1 transcription factor network—LAMA4—dilated cardiomyopathy	0.000499	0.0399	CbGpPWpGaD
Clomifene—ESR1—Nuclear Receptor transcription pathway—NR3C2—dilated cardiomyopathy	0.000363	0.029	CbGpPWpGaD
Clomifene—ESR1—Regulation of nuclear SMAD2/3 signaling—ZBTB17—dilated cardiomyopathy	0.00034	0.0272	CbGpPWpGaD
Clomifene—KCNH2—SIDS Susceptibility Pathways—SCN5A—dilated cardiomyopathy	0.000333	0.0266	CbGpPWpGaD
Clomifene—KCNH2—Potassium Channels—ABCC9—dilated cardiomyopathy	0.000308	0.0246	CbGpPWpGaD
Clomifene—EBP—Metabolism of lipids and lipoproteins—ANKRD1—dilated cardiomyopathy	0.000297	0.0237	CbGpPWpGaD
Clomifene—EBP—Metabolism of lipids and lipoproteins—TAZ—dilated cardiomyopathy	0.000279	0.0223	CbGpPWpGaD
Clomifene—ESR1—Nuclear signaling by ERBB4—PSEN2—dilated cardiomyopathy	0.000274	0.0219	CbGpPWpGaD
Clomifene—ESR1—LKB1 signaling events—PSEN2—dilated cardiomyopathy	0.000253	0.0202	CbGpPWpGaD
Clomifene—KCNH2—SIDS Susceptibility Pathways—RYR2—dilated cardiomyopathy	0.000237	0.0189	CbGpPWpGaD
Clomifene—ABCB1—ABC-family proteins mediated transport—ABCC9—dilated cardiomyopathy	0.000236	0.0189	CbGpPWpGaD
Clomifene—CYP19A1—FSH signaling pathway—RPS6KB1—dilated cardiomyopathy	0.000228	0.0183	CbGpPWpGaD
Clomifene—CYP1A1—PPARA activates gene expression—ANKRD1—dilated cardiomyopathy	0.000188	0.015	CbGpPWpGaD
Clomifene—CYP1A1—Melatonin metabolism and effects—ADRB1—dilated cardiomyopathy	0.000184	0.0147	CbGpPWpGaD
Clomifene—CYP1A1—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—ANKRD1—dilated cardiomyopathy	0.000184	0.0147	CbGpPWpGaD
Clomifene—ESR1—AP-1 transcription factor network—NPPA—dilated cardiomyopathy	0.000177	0.0141	CbGpPWpGaD
Clomifene—CYP11A1—Corticotropin-releasing hormone—GJA1—dilated cardiomyopathy	0.000153	0.0123	CbGpPWpGaD
Clomifene—CYP19A1—FSH signaling pathway—RAF1—dilated cardiomyopathy	0.000137	0.0109	CbGpPWpGaD
Clomifene—KCNH2—Neuronal System—ABCC9—dilated cardiomyopathy	0.000135	0.0108	CbGpPWpGaD
Clomifene—EBP—Metabolism—ANKRD1—dilated cardiomyopathy	0.000132	0.0106	CbGpPWpGaD
Clomifene—KCNH2—Neuronal System—ACTN2—dilated cardiomyopathy	0.000129	0.0103	CbGpPWpGaD
Clomifene—CYP1A1—Oxidative Stress—SOD2—dilated cardiomyopathy	0.000129	0.0103	CbGpPWpGaD
Clomifene—CYP11A1—Metabolism of lipids and lipoproteins—ANKRD1—dilated cardiomyopathy	0.000128	0.0103	CbGpPWpGaD
Clomifene—ESR1—Aryl Hydrocarbon Receptor—CD36—dilated cardiomyopathy	0.000128	0.0102	CbGpPWpGaD
Clomifene—CYP1A1—Fatty acid, triacylglycerol, and ketone body metabolism—ANKRD1—dilated cardiomyopathy	0.000127	0.0101	CbGpPWpGaD
Clomifene—ESR1—Integrated Pancreatic Cancer Pathway—PLN—dilated cardiomyopathy	0.000126	0.0101	CbGpPWpGaD
Clomifene—EBP—Metabolism—TAZ—dilated cardiomyopathy	0.000124	0.00992	CbGpPWpGaD
Clomifene—CYP1A1—Oxidative Stress—GPX1—dilated cardiomyopathy	0.000123	0.00979	CbGpPWpGaD
Clomifene—CYP11A1—Metabolism of lipids and lipoproteins—TAZ—dilated cardiomyopathy	0.000121	0.00964	CbGpPWpGaD
Clomifene—CYP1A2—Melatonin metabolism and effects—ADRB1—dilated cardiomyopathy	0.000117	0.00936	CbGpPWpGaD
Clomifene—ESR1—AP-1 transcription factor network—GJA1—dilated cardiomyopathy	0.000113	0.00904	CbGpPWpGaD
Clomifene—EBP—Metabolism—SDHA—dilated cardiomyopathy	0.000112	0.00897	CbGpPWpGaD
Clomifene—ESR1—AP-1 transcription factor network—IL10—dilated cardiomyopathy	9.81e-05	0.00784	CbGpPWpGaD
Clomifene—ESR1—Regulation of Telomerase—RPS6KB1—dilated cardiomyopathy	9.77e-05	0.0078	CbGpPWpGaD
Clomifene—CYP2E1—Vitamin A and Carotenoid Metabolism—CD36—dilated cardiomyopathy	9.49e-05	0.00758	CbGpPWpGaD
Clomifene—KCNH2—SIDS Susceptibility Pathways—GJA1—dilated cardiomyopathy	9.25e-05	0.00739	CbGpPWpGaD
Clomifene—ESR1—Signaling by ERBB4—PSEN2—dilated cardiomyopathy	9.22e-05	0.00737	CbGpPWpGaD
Clomifene—ESR1—Leptin signaling pathway—RPS6KB1—dilated cardiomyopathy	9.03e-05	0.00722	CbGpPWpGaD
Clomifene—ESR1—Regulation of nuclear SMAD2/3 signaling—IL10—dilated cardiomyopathy	8.73e-05	0.00697	CbGpPWpGaD
Clomifene—CYP19A1—Metabolism of lipids and lipoproteins—ANKRD1—dilated cardiomyopathy	8.5e-05	0.00679	CbGpPWpGaD
Clomifene—CYP1A1—Aryl Hydrocarbon Receptor—CD36—dilated cardiomyopathy	8.48e-05	0.00678	CbGpPWpGaD
Clomifene—ESR1—AP-1 transcription factor network—AGT—dilated cardiomyopathy	8.24e-05	0.00658	CbGpPWpGaD
Clomifene—ESR1—Leptin signaling pathway—RAC1—dilated cardiomyopathy	8.16e-05	0.00652	CbGpPWpGaD
Clomifene—CYP1A1—Arachidonic acid metabolism—GPX1—dilated cardiomyopathy	8.15e-05	0.00651	CbGpPWpGaD
Clomifene—KCNH2—SIDS Susceptibility Pathways—IL10—dilated cardiomyopathy	8.02e-05	0.00641	CbGpPWpGaD
Clomifene—ESR1—Aryl Hydrocarbon Receptor—RAF1—dilated cardiomyopathy	8e-05	0.00639	CbGpPWpGaD
Clomifene—CYP19A1—Metabolism of lipids and lipoproteins—TAZ—dilated cardiomyopathy	7.99e-05	0.00638	CbGpPWpGaD
Clomifene—CYP11A1—Corticotropin-releasing hormone—RAF1—dilated cardiomyopathy	7.75e-05	0.00619	CbGpPWpGaD
Clomifene—EBP—Metabolism of lipids and lipoproteins—GPX1—dilated cardiomyopathy	6.85e-05	0.00547	CbGpPWpGaD
Clomifene—ABCB1—Integrated Pancreatic Cancer Pathway—PLN—dilated cardiomyopathy	6.68e-05	0.00534	CbGpPWpGaD
Clomifene—EBP—Metabolism of lipids and lipoproteins—CD36—dilated cardiomyopathy	6.67e-05	0.00533	CbGpPWpGaD
Clomifene—ESR1—Generic Transcription Pathway—NR3C2—dilated cardiomyopathy	6.27e-05	0.00501	CbGpPWpGaD
Clomifene—EBP—Metabolism of lipids and lipoproteins—AGT—dilated cardiomyopathy	6.01e-05	0.0048	CbGpPWpGaD
Clomifene—CYP11A1—Metabolism—ANKRD1—dilated cardiomyopathy	5.71e-05	0.00457	CbGpPWpGaD
Clomifene—ABCB1—Allograft Rejection—AGTR1—dilated cardiomyopathy	5.62e-05	0.00449	CbGpPWpGaD
Clomifene—ESR1—Aryl Hydrocarbon Receptor—EGFR—dilated cardiomyopathy	5.49e-05	0.00438	CbGpPWpGaD
Clomifene—ESR1—Leptin signaling pathway—RAF1—dilated cardiomyopathy	5.41e-05	0.00432	CbGpPWpGaD
Clomifene—CYP1A2—Aryl Hydrocarbon Receptor—CD36—dilated cardiomyopathy	5.41e-05	0.00432	CbGpPWpGaD
Clomifene—CYP11A1—Metabolism—TAZ—dilated cardiomyopathy	5.37e-05	0.00429	CbGpPWpGaD
Clomifene—CYP1A1—Aryl Hydrocarbon Receptor—RAF1—dilated cardiomyopathy	5.3e-05	0.00423	CbGpPWpGaD
Clomifene—ESR1—Aryl Hydrocarbon Receptor—TNF—dilated cardiomyopathy	5.23e-05	0.00417	CbGpPWpGaD
Clomifene—CYP19A1—Integrated Breast Cancer Pathway—RAC1—dilated cardiomyopathy	5.21e-05	0.00416	CbGpPWpGaD
Clomifene—CYP1A2—Arachidonic acid metabolism—GPX1—dilated cardiomyopathy	5.19e-05	0.00415	CbGpPWpGaD
Clomifene—CYP1A1—Metabolism of lipids and lipoproteins—ANKRD1—dilated cardiomyopathy	5.04e-05	0.00403	CbGpPWpGaD
Clomifene—CYP11A1—Metabolism—SDHA—dilated cardiomyopathy	4.86e-05	0.00388	CbGpPWpGaD
Clomifene—CYP1A1—Metabolism of lipids and lipoproteins—TAZ—dilated cardiomyopathy	4.74e-05	0.00379	CbGpPWpGaD
Clomifene—ABCB1—Allograft Rejection—IL10—dilated cardiomyopathy	4.71e-05	0.00376	CbGpPWpGaD
Clomifene—ESR1—Integrated Breast Cancer Pathway—RAC1—dilated cardiomyopathy	4.66e-05	0.00372	CbGpPWpGaD
Clomifene—ABCB1—Allograft Rejection—FASLG—dilated cardiomyopathy	4.38e-05	0.0035	CbGpPWpGaD
Clomifene—ABCB1—Allograft Rejection—FAS—dilated cardiomyopathy	4.22e-05	0.00337	CbGpPWpGaD
Clomifene—CYP1A1—PPARA activates gene expression—CD36—dilated cardiomyopathy	4.22e-05	0.00337	CbGpPWpGaD
Clomifene—CYP1A1—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—CD36—dilated cardiomyopathy	4.13e-05	0.0033	CbGpPWpGaD
Clomifene—ESR1—Integrated Pancreatic Cancer Pathway—FASLG—dilated cardiomyopathy	4.09e-05	0.00326	CbGpPWpGaD
Clomifene—ESR1—Regulation of Telomerase—EGFR—dilated cardiomyopathy	4.01e-05	0.00321	CbGpPWpGaD
Clomifene—ESR1—Generic Transcription Pathway—NPPA—dilated cardiomyopathy	3.94e-05	0.00315	CbGpPWpGaD
Clomifene—ESR1—Integrated Pancreatic Cancer Pathway—FAS—dilated cardiomyopathy	3.94e-05	0.00315	CbGpPWpGaD
Clomifene—ESR1—Integrated Pancreatic Cancer Pathway—RAC1—dilated cardiomyopathy	3.86e-05	0.00309	CbGpPWpGaD
Clomifene—CYP1A1—PPARA activates gene expression—AGT—dilated cardiomyopathy	3.8e-05	0.00304	CbGpPWpGaD
Clomifene—CYP19A1—Metabolism—ANKRD1—dilated cardiomyopathy	3.79e-05	0.00302	CbGpPWpGaD
Clomifene—CYP1A1—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—AGT—dilated cardiomyopathy	3.72e-05	0.00297	CbGpPWpGaD
Clomifene—CYP1A1—Aryl Hydrocarbon Receptor—EGFR—dilated cardiomyopathy	3.63e-05	0.0029	CbGpPWpGaD
Clomifene—CYP1A1—Aryl Hydrocarbon Receptor Pathway—EGFR—dilated cardiomyopathy	3.63e-05	0.0029	CbGpPWpGaD
Clomifene—CYP19A1—Metabolism—TAZ—dilated cardiomyopathy	3.56e-05	0.00284	CbGpPWpGaD
Clomifene—CYP1A1—Aryl Hydrocarbon Receptor Pathway—TNF—dilated cardiomyopathy	3.46e-05	0.00276	CbGpPWpGaD
Clomifene—CYP1A1—Aryl Hydrocarbon Receptor—TNF—dilated cardiomyopathy	3.46e-05	0.00276	CbGpPWpGaD
Clomifene—CYP1A2—Aryl Hydrocarbon Receptor—RAF1—dilated cardiomyopathy	3.38e-05	0.0027	CbGpPWpGaD
Clomifene—CYP19A1—Metabolism—SDHA—dilated cardiomyopathy	3.22e-05	0.00257	CbGpPWpGaD
Clomifene—CYP1A2—Metabolism of lipids and lipoproteins—ANKRD1—dilated cardiomyopathy	3.21e-05	0.00257	CbGpPWpGaD
Clomifene—ESR1—Signaling by ERBB4—RAF1—dilated cardiomyopathy	3.08e-05	0.00246	CbGpPWpGaD
Clomifene—KCNH2—SIDS Susceptibility Pathways—TNF—dilated cardiomyopathy	3.05e-05	0.00244	CbGpPWpGaD
Clomifene—EBP—Metabolism—GPX1—dilated cardiomyopathy	3.05e-05	0.00244	CbGpPWpGaD
Clomifene—CYP1A2—Metabolism of lipids and lipoproteins—TAZ—dilated cardiomyopathy	3.02e-05	0.00241	CbGpPWpGaD
Clomifene—ESR1—Gene Expression—NR3C2—dilated cardiomyopathy	3.02e-05	0.00241	CbGpPWpGaD
Clomifene—CYP2A6—Metabolism—ANKRD1—dilated cardiomyopathy	3.01e-05	0.00241	CbGpPWpGaD
Clomifene—EBP—Metabolism—CD36—dilated cardiomyopathy	2.97e-05	0.00237	CbGpPWpGaD
Clomifene—CYP11A1—Metabolism of lipids and lipoproteins—GPX1—dilated cardiomyopathy	2.96e-05	0.00237	CbGpPWpGaD
Clomifene—KCNH2—Neuronal System—RAF1—dilated cardiomyopathy	2.94e-05	0.00235	CbGpPWpGaD
Clomifene—CYP11A1—Metabolism of lipids and lipoproteins—CD36—dilated cardiomyopathy	2.89e-05	0.00231	CbGpPWpGaD
Clomifene—CYP1A1—Fatty acid, triacylglycerol, and ketone body metabolism—CD36—dilated cardiomyopathy	2.85e-05	0.00227	CbGpPWpGaD
Clomifene—CYP2A6—Metabolism—TAZ—dilated cardiomyopathy	2.83e-05	0.00226	CbGpPWpGaD
Clomifene—ABCB1—Transmembrane transport of small molecules—RYR2—dilated cardiomyopathy	2.73e-05	0.00218	CbGpPWpGaD
Clomifene—EBP—Metabolism—AGT—dilated cardiomyopathy	2.68e-05	0.00214	CbGpPWpGaD
Clomifene—ABCB1—Transmembrane transport of small molecules—SLC22A5—dilated cardiomyopathy	2.65e-05	0.00212	CbGpPWpGaD
Clomifene—ABCB1—Transmembrane transport of small molecules—PLN—dilated cardiomyopathy	2.65e-05	0.00212	CbGpPWpGaD
Clomifene—CYP11A1—Metabolism of lipids and lipoproteins—AGT—dilated cardiomyopathy	2.6e-05	0.00208	CbGpPWpGaD
Clomifene—CYP1A1—Fatty acid, triacylglycerol, and ketone body metabolism—AGT—dilated cardiomyopathy	2.56e-05	0.00205	CbGpPWpGaD
Clomifene—CYP2A6—Metabolism—SDHA—dilated cardiomyopathy	2.56e-05	0.00205	CbGpPWpGaD
Clomifene—ESR1—Integrated Pancreatic Cancer Pathway—RAF1—dilated cardiomyopathy	2.56e-05	0.00205	CbGpPWpGaD
Clomifene—ABCB1—Transmembrane transport of small molecules—ABCC9—dilated cardiomyopathy	2.47e-05	0.00197	CbGpPWpGaD
Clomifene—CYP2E1—Metabolism—ANKRD1—dilated cardiomyopathy	2.38e-05	0.0019	CbGpPWpGaD
Clomifene—CYP19A1—Integrated Breast Cancer Pathway—EGFR—dilated cardiomyopathy	2.37e-05	0.00189	CbGpPWpGaD
Clomifene—CYP1A2—Aryl Hydrocarbon Receptor—EGFR—dilated cardiomyopathy	2.32e-05	0.00185	CbGpPWpGaD
Clomifene—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EGFR—dilated cardiomyopathy	2.32e-05	0.00185	CbGpPWpGaD
Clomifene—CYP1A1—Metabolism—ANKRD1—dilated cardiomyopathy	2.24e-05	0.00179	CbGpPWpGaD
Clomifene—CYP2E1—Metabolism—TAZ—dilated cardiomyopathy	2.24e-05	0.00179	CbGpPWpGaD
Clomifene—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—dilated cardiomyopathy	2.21e-05	0.00176	CbGpPWpGaD
Clomifene—CYP1A2—Aryl Hydrocarbon Receptor—TNF—dilated cardiomyopathy	2.21e-05	0.00176	CbGpPWpGaD
Clomifene—ABCB1—Integrated Pancreatic Cancer Pathway—FASLG—dilated cardiomyopathy	2.16e-05	0.00173	CbGpPWpGaD
Clomifene—ESR1—Integrated Breast Cancer Pathway—EGFR—dilated cardiomyopathy	2.12e-05	0.00169	CbGpPWpGaD
Clomifene—CYP1A1—Metabolism—TAZ—dilated cardiomyopathy	2.11e-05	0.00169	CbGpPWpGaD
Clomifene—ESR1—Signaling by ERBB4—EGFR—dilated cardiomyopathy	2.11e-05	0.00168	CbGpPWpGaD
Clomifene—ABCB1—Integrated Pancreatic Cancer Pathway—FAS—dilated cardiomyopathy	2.08e-05	0.00167	CbGpPWpGaD
Clomifene—ABCB1—Integrated Pancreatic Cancer Pathway—RAC1—dilated cardiomyopathy	2.04e-05	0.00163	CbGpPWpGaD
Clomifene—CYP2E1—Metabolism—SDHA—dilated cardiomyopathy	2.02e-05	0.00162	CbGpPWpGaD
Clomifene—CYP19A1—Metabolism of lipids and lipoproteins—GPX1—dilated cardiomyopathy	1.96e-05	0.00157	CbGpPWpGaD
Clomifene—CYP19A1—Metabolism of lipids and lipoproteins—CD36—dilated cardiomyopathy	1.91e-05	0.00153	CbGpPWpGaD
Clomifene—CYP1A1—Metabolism—SDHA—dilated cardiomyopathy	1.91e-05	0.00152	CbGpPWpGaD
Clomifene—ESR1—Gene Expression—NPPA—dilated cardiomyopathy	1.9e-05	0.00152	CbGpPWpGaD
Clomifene—ABCB1—Allograft Rejection—TNF—dilated cardiomyopathy	1.79e-05	0.00143	CbGpPWpGaD
Clomifene—ABCB1—Metabolism—ANKRD1—dilated cardiomyopathy	1.79e-05	0.00143	CbGpPWpGaD
Clomifene—ESR1—Integrated Pancreatic Cancer Pathway—EGFR—dilated cardiomyopathy	1.76e-05	0.0014	CbGpPWpGaD
Clomifene—CYP19A1—Metabolism of lipids and lipoproteins—AGT—dilated cardiomyopathy	1.72e-05	0.00138	CbGpPWpGaD
Clomifene—ABCB1—Metabolism—TAZ—dilated cardiomyopathy	1.69e-05	0.00135	CbGpPWpGaD
Clomifene—ESR1—Integrated Pancreatic Cancer Pathway—TNF—dilated cardiomyopathy	1.67e-05	0.00134	CbGpPWpGaD
Clomifene—ABCB1—Metabolism—SDHA—dilated cardiomyopathy	1.52e-05	0.00122	CbGpPWpGaD
Clomifene—CYP1A2—Metabolism—ANKRD1—dilated cardiomyopathy	1.43e-05	0.00114	CbGpPWpGaD
Clomifene—ABCB1—Integrated Pancreatic Cancer Pathway—RAF1—dilated cardiomyopathy	1.36e-05	0.00108	CbGpPWpGaD
Clomifene—CYP1A2—Metabolism—TAZ—dilated cardiomyopathy	1.35e-05	0.00108	CbGpPWpGaD
Clomifene—CYP11A1—Metabolism—GPX1—dilated cardiomyopathy	1.32e-05	0.00105	CbGpPWpGaD
Clomifene—CYP11A1—Metabolism—CD36—dilated cardiomyopathy	1.29e-05	0.00103	CbGpPWpGaD
Clomifene—CYP1A2—Metabolism—SDHA—dilated cardiomyopathy	1.22e-05	0.000972	CbGpPWpGaD
Clomifene—ESR1—Signaling Pathways—PSEN2—dilated cardiomyopathy	1.19e-05	0.000954	CbGpPWpGaD
Clomifene—CYP1A1—Metabolism of lipids and lipoproteins—GPX1—dilated cardiomyopathy	1.16e-05	0.00093	CbGpPWpGaD
Clomifene—CYP11A1—Metabolism—AGT—dilated cardiomyopathy	1.16e-05	0.000925	CbGpPWpGaD
Clomifene—CYP1A1—Metabolism of lipids and lipoproteins—CD36—dilated cardiomyopathy	1.13e-05	0.000906	CbGpPWpGaD
Clomifene—CYP3A4—Metabolism—ANKRD1—dilated cardiomyopathy	1.1e-05	0.000883	CbGpPWpGaD
Clomifene—ESR1—Signaling Pathways—CXCL2—dilated cardiomyopathy	1.06e-05	0.000847	CbGpPWpGaD
Clomifene—ESR1—Signaling Pathways—AGTR2—dilated cardiomyopathy	1.06e-05	0.000847	CbGpPWpGaD
Clomifene—CYP3A4—Metabolism—TAZ—dilated cardiomyopathy	1.04e-05	0.00083	CbGpPWpGaD
Clomifene—CYP1A1—Metabolism of lipids and lipoproteins—AGT—dilated cardiomyopathy	1.02e-05	0.000816	CbGpPWpGaD
Clomifene—ESR1—Signaling Pathways—CXCR3—dilated cardiomyopathy	9.86e-06	0.000788	CbGpPWpGaD
Clomifene—ESR1—Signaling Pathways—ADRB1—dilated cardiomyopathy	9.55e-06	0.000763	CbGpPWpGaD
Clomifene—CYP3A4—Metabolism—SDHA—dilated cardiomyopathy	9.39e-06	0.00075	CbGpPWpGaD
Clomifene—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—dilated cardiomyopathy	9.29e-06	0.000742	CbGpPWpGaD
Clomifene—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—dilated cardiomyopathy	8.85e-06	0.000707	CbGpPWpGaD
Clomifene—CYP19A1—Metabolism—GPX1—dilated cardiomyopathy	8.74e-06	0.000698	CbGpPWpGaD
Clomifene—CYP19A1—Metabolism—CD36—dilated cardiomyopathy	8.52e-06	0.00068	CbGpPWpGaD
Clomifene—ESR1—Signaling Pathways—AGTR1—dilated cardiomyopathy	8.16e-06	0.000652	CbGpPWpGaD
Clomifene—ESR1—Signaling Pathways—ADRB2—dilated cardiomyopathy	7.74e-06	0.000618	CbGpPWpGaD
Clomifene—CYP19A1—Metabolism—AGT—dilated cardiomyopathy	7.67e-06	0.000612	CbGpPWpGaD
Clomifene—CYP1A2—Metabolism of lipids and lipoproteins—GPX1—dilated cardiomyopathy	7.42e-06	0.000593	CbGpPWpGaD
Clomifene—CYP1A2—Metabolism of lipids and lipoproteins—CD36—dilated cardiomyopathy	7.23e-06	0.000578	CbGpPWpGaD
Clomifene—CYP2A6—Metabolism—GPX1—dilated cardiomyopathy	6.96e-06	0.000556	CbGpPWpGaD
Clomifene—CYP2A6—Metabolism—CD36—dilated cardiomyopathy	6.78e-06	0.000541	CbGpPWpGaD
Clomifene—ESR1—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	6.65e-06	0.000531	CbGpPWpGaD
Clomifene—CYP1A2—Metabolism of lipids and lipoproteins—AGT—dilated cardiomyopathy	6.51e-06	0.00052	CbGpPWpGaD
Clomifene—CYP2A6—Metabolism—AGT—dilated cardiomyopathy	6.1e-06	0.000488	CbGpPWpGaD
Clomifene—ESR1—Signaling Pathways—RAC1—dilated cardiomyopathy	6.01e-06	0.00048	CbGpPWpGaD
Clomifene—ESR1—Signaling Pathways—AGT—dilated cardiomyopathy	5.74e-06	0.000458	CbGpPWpGaD
Clomifene—CYP2E1—Metabolism—GPX1—dilated cardiomyopathy	5.5e-06	0.000439	CbGpPWpGaD
Clomifene—ABCB1—Transmembrane transport of small molecules—RAF1—dilated cardiomyopathy	5.38e-06	0.00043	CbGpPWpGaD
Clomifene—CYP2E1—Metabolism—CD36—dilated cardiomyopathy	5.36e-06	0.000428	CbGpPWpGaD
Clomifene—CYP1A1—Metabolism—GPX1—dilated cardiomyopathy	5.19e-06	0.000414	CbGpPWpGaD
Clomifene—CYP1A1—Metabolism—CD36—dilated cardiomyopathy	5.05e-06	0.000403	CbGpPWpGaD
Clomifene—CYP2E1—Metabolism—AGT—dilated cardiomyopathy	4.82e-06	0.000385	CbGpPWpGaD
Clomifene—CYP1A1—Metabolism—AGT—dilated cardiomyopathy	4.55e-06	0.000363	CbGpPWpGaD
Clomifene—ABCB1—Metabolism—GPX1—dilated cardiomyopathy	4.14e-06	0.000331	CbGpPWpGaD
Clomifene—ABCB1—Metabolism—CD36—dilated cardiomyopathy	4.03e-06	0.000322	CbGpPWpGaD
Clomifene—ESR1—Signaling Pathways—RAF1—dilated cardiomyopathy	3.98e-06	0.000318	CbGpPWpGaD
Clomifene—ABCB1—Metabolism—AGT—dilated cardiomyopathy	3.63e-06	0.00029	CbGpPWpGaD
Clomifene—CYP1A2—Metabolism—GPX1—dilated cardiomyopathy	3.31e-06	0.000264	CbGpPWpGaD
Clomifene—CYP1A2—Metabolism—CD36—dilated cardiomyopathy	3.22e-06	0.000257	CbGpPWpGaD
Clomifene—CYP1A2—Metabolism—AGT—dilated cardiomyopathy	2.9e-06	0.000232	CbGpPWpGaD
Clomifene—ESR1—Signaling Pathways—EGFR—dilated cardiomyopathy	2.73e-06	0.000218	CbGpPWpGaD
Clomifene—CYP3A4—Metabolism—GPX1—dilated cardiomyopathy	2.55e-06	0.000204	CbGpPWpGaD
Clomifene—CYP3A4—Metabolism—CD36—dilated cardiomyopathy	2.49e-06	0.000199	CbGpPWpGaD
Clomifene—CYP3A4—Metabolism—AGT—dilated cardiomyopathy	2.24e-06	0.000179	CbGpPWpGaD
